Pines A, Giladi M, Moshkowitz M, Finkelstein A, Levo Y
Harefuah. 1989 Mar 15;116(6):311-2.
Pneumocystis carinii pneumonia (PCP) is the major cause of death in AIDS. The use of standard drugs for PCP is associated with a remarkably high rate of adverse reactions in AIDS patients. We treated a 35-year-old homosexual with a first episode of PCP with intravenous trimethoprim, 20 mg/kg, and sulfamethoxazole, 100 mg/kg and later with pentamidine injections. However medication had to be stopped because of severe side effects. A new method of therapy using aerosolized pentamidine (300 mg per inhalation, daily) was then applied successfully. The patient recovered and has been having prophylactic inhalations and getting azothymidine for the past 8 months. In studies on relatively small numbers of patients this treatment has been reported to give good results with only minor side effects. However, further data are needed, especially on the optimal characteristics of the generated aerosol and the best delivery system.
卡氏肺孢子虫肺炎(PCP)是艾滋病患者的主要死因。用于治疗PCP的标准药物在艾滋病患者中会引发极高的不良反应率。我们治疗了一名35岁的同性恋男性,他首次发作PCP,先静脉注射甲氧苄啶(20mg/kg)和磺胺甲恶唑(100mg/kg),之后又进行喷他脒注射。然而,由于严重的副作用,药物治疗不得不停止。随后成功应用了一种新的治疗方法,即雾化喷他脒(每次吸入300mg,每日一次)。患者康复,在过去8个月里一直进行预防性吸入治疗并服用叠氮胸苷。在针对相对少数患者的研究中,据报道这种治疗效果良好,副作用较小。然而,还需要更多数据,尤其是关于所产生气雾剂的最佳特性和最佳给药系统的数据。